Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and ...
AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant ...
Rein Therapeutics (NASDAQ:RNTX) stock is trading higher on Monday, with a session volume of 41.2 million compared to its average volume of 162.67 thousand, according to data from Benzinga Pro. What ...
REIN has about 8,000 licensed members and 9,263 total members. It serves an area that stretches from Williamsburg and Gloucester down to Moyock, Edenton and Elizabeth City, North Carolina. Members of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results